Non-Small Cell Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Non-Small Cell Lung Cancer with an EGFR Mutation

Research To Practice | Oncology Videos

Sisällön tarjoaa Dr Neil Love. Dr Neil Love tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

23d ago 1:29:08

QUICKTIME•Jakson koti

Featuring perspectives from Ms Marianne J Davies, Dr Alexander I Spira, Ms Jillian Thompson and Dr Helena Yu, including the following topics:

Introduction (0:00)
The Importance of EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) (7:02)
The Role of Osimertinib in Managing Localized and Locally Advanced NSCLC with an EGFR Mutation (11:58)
Established First-Line Therapy for Metastatic NSCLC with an EGFR Mutation (32:38)
Newly Approved and Promising Investigational Approaches to First-Line Therapy for Metastatic NSCLC with an EGFR Mutation (37:45)
Common Toxicities Associated with Amivantamab (45:07)
The Current and Future Management of Progressive NSCLC with an EGFR Mutation (55:06)
Tolerability and Other Practical Considerations with HER3-DXd (1:01:06)
Treatment for Metastatic NSCLC with EGFR Exon 20 Insertion Mutations (1:18:26)

NCPD information and select publications

1300 jaksoa

#Science #Medicine #Cancer #Neillove #Oncology #Researchtopractice #Fitness #Dr Neil Love #Video